- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
streptolysin O (streptolysin O) antibody and antigen (Recombinant protein)
Diagnostic streptolysin O (SLO) antibodies (anti-streptolysin O, anti-streptolysin O) and antigens (recombinant streptolysin O (SLO) protein) for Infectious disease streptolysin O detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-IVD-P042-Tg001-Ag01 | Recombinant human streptolysin O (SLO) streptolysin O Protein | 3090 |
| GMP-IVD-P042-Tg001-Ab01 | Anti-human streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb) | 1953 |
| GMP-IVD-P042-Tg001-Ab02 | Anti-human streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb) | 1953 |
| GMP-IVD-P042-Tg001-Ab03 | Anti-human streptolysin O (SLO) streptolysin O human monoclonal antibody (mAb) | 1953 |
| GMP-IVD-P042-Tg001-Ab04 | Anti-human streptolysin O (SLO) streptolysin O human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-IVD-P042-Tg001-Ag01 |
| Product Name | Recombinant human streptolysin O (SLO) streptolysin O Protein |
| Pathogen | streptolysin O |
| Target/Biomarker | streptolysin O(streptolysin O) |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | streptolysin O (streptolysin O) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in streptolysin O level test of Infectious disease (Streptococcus pyogenes infection) and related syndrome evaluation. |
| Tag | His |
| Products description | Recombinant human streptolysin O (SLO) streptolysin O Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-IVD-P042-Tg001-Ab01, GMP-IVD-P042-Tg001-Ab02 |
| Product Name | Anti-human streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb) |
| Pathogen | streptolysin O |
| Target/Biomarker | streptolysin O(streptolysin O) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human streptolysin O (streptolysin O) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other streptolysin O (streptolysin O) antibodies in streptolysin O level test of Infectious disease (Streptococcus pyogenes infection) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-IVD-P042-Tg001-Ab03, GMP-IVD-P042-Tg001-Ab04 |
| Product Name | Anti-human streptolysin O (SLO) streptolysin O human monoclonal antibody (mAb) |
| Pathogen | streptolysin O |
| Target/Biomarker | streptolysin O(streptolysin O) |
| Expression platform | CHO |
| Isotypes | Human IgG1 |
| Bioactivity validation | Human streptolysin O (streptolysin O) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other streptolysin O (streptolysin O) antibodies in streptolysin O level test of Infectious disease (Streptococcus pyogenes infection) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human streptolysin O (SLO) streptolysin O human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Anti-streptolysin O (anti-SLO, ASO) is an antibody targeted against streptolysin O, a toxic enzyme produced by group A Streptococcus bacteria. ASO and anti-DNase B are the most common of several antibodies that are produced by the body's immune system in response to a strep infection with group A Streptococcus. This test measures the amount of ASO in the blood. Group A Streptococcus (Streptococcus pyogenes) is the bacterium responsible for causing strep throat and a variety of other infections, including skin infections (pyoderma, impetigo, cellulitis). In most cases, strep infections are identified and treated with antibiotics, and the infections resolve. When a strep infection does not cause identifiable symptoms, goes untreated, or is treated ineffectively, however, complications, namely rheumatic fever and a type of kidney disease (glomerulonephritis), can sometimes develop, especially in young children. These secondary conditions have become much less prevalent in the U.S. because of routine strep testing, but they still do occur. These conditions can cause serious complications such as heart damage, acute kidney dysfunction, tissue swelling (edema), and high blood pressure (hypertension). The ASO test can be used to help determine if these are due to a recent group A strep infection.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments